SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Introgen Therapeutics
An SI Board Since February 2004
Posts SubjectMarks Bans Symbol
802 21 0 INGN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
302Topotecan in the Treatment of Recurrent Small Cell Lung Cancer: An Update Andreazeta19615/16/2005
301Thanks Bernard..I think it's impressive even if small #'s...these patienzeta19615/16/2005
300Some Comments on INGN225 at ASCO Bernard. . <b> Introgen's NovJibacoa5/16/2005
299<ASCO> thanks to YMB Initial results of a Phase II trial of patients wzeta19615/16/2005
298Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptozeta19615/15/2005
297<i>I don't plan on buying until it can close above the Dec.9 H at 9.81zeta19615/14/2005
296<i> But will trade it<g>Pulled the sell trigger immed. post CC, saveJibacoa5/13/2005
295Ay, caramba..es mi culpa, es mi culpa, perdóname por favor<g> <i&zeta19615/13/2005
294You are getting behind. (This is 2 days old.<g>) Bernard Introgen TherapJibacoa5/13/2005
293Under the Microscope again Some investors show new interest in gene therapy, deszeta19615/10/2005
292Tumor Suppressor P53 Inhibits Replication Of Hepatitis C Virus Subgenomic Repliczeta19615/8/2005
291Message 21299122zeta19615/6/2005
290What's up with that Bernard?..couldn't excercise @ 39cents 'cuz of izeta19615/5/2005
289Both Nance and Enloe were granted new shares to compensate them for the options Jibacoa5/5/2005
288First Quarter 2005 Earnings Conference Call on Tuesday, May 10 at 4:30 EDT ThisJibacoa5/5/2005
287Cancer Res. 2005 Apr 15;65(8):3307-18. Related Articles, Links [senior author zeta19614/27/2005
286Form 8-K for INTROGEN THERAPEUTICS INC [I don't know what to make of this.zeta19614/25/2005
285INGN Removed from Naked Short List Today The link is www.buyins.net and click oTom Ronk4/21/2005
284Beranrd..these abstracts are greek to them<g> Perhaps you can whip up a czeta19614/19/2005
283<i> INGN is conducting two Phase III trials using Advexin, for head and neJibacoa4/19/2005
282<i> The 12-month target price is set to $18. </i> It seems that I wJibacoa4/19/2005
281>Introgen Therapeutics initiated with "strong buy" [from YMB] Monzeta19614/19/2005
280Thanks Z, I will start following that thread. Tobtobrntob4/18/2005
279Bernard..thanks!..Rick has been keeping me busy with MYGN..hope you and Nance dozeta19614/18/2005
278Introgen is making some comments on its INGN241 (I always liked INGN241 more thaJibacoa4/18/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News